Lufirinz 1% Cream contains luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. Lufirinz 1% Cream is effective against a broad spectrum of dermatophytes such as Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, as well as yeasts like Candida species and Malassezia furfur. The cream formulation ensures optimal skin penetration and sustained antifungal activity, making it suitable for once-daily application. Clinical studies have demonstrated its efficacy in resolving signs and symptoms of fungal infections with a typical treatment duration ranging from one to two weeks, depending on the infection type and severity. Lufirinz 1% Cream is generally well tolerated, with minimal local adverse effects such as mild burning or irritation reported infrequently. It is contraindicated in patients with known hypersensitivity to luliconazole or any cream excipients. For optimal results, patients should adhere to the prescribed treatment regimen and maintain proper hygiene to prevent reinfection.